| [1] |
Khan P, Fatima M, Khan MA，et al. Emerging role of chemokines in small cell lung cancer：Road signs for metastasis，heterogeneity，and immune response[J]. Semin Cancer Biol， 2022, 87:117-126. DOI： 10.1016/j.semcancer.2022.11.005.
|
| [2] |
Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy[J]. Nat Rev Immunol， 2017, 17(9):559-572. DOI： 10.1038/nri.2017.49.
|
| [3] |
Ratajczak MZ, Zuba-Surma E, Kucia M，et al. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis，regeneration and tumorigenesis[J]. Leukemia， 2006, 20(11):1915-1924. DOI： 10.1038/sj.leu.2404357.
|
| [4] |
Broussas M, Boute N, Akla B，et al. A new anti-CXCR4 antibody that blocks the CXCR4/SDF-1 axis and mobilizes effector cells[J]. Mol Cancer Ther， 2016, 15(8):1890-1899. DOI： 10.1158/1535-7163.MCT-16-0041.
|
| [5] |
Sadri F, Rezaei Z, Fereidouni M. The significance of the SDF-1/CXCR4 signaling pathway in the normal development[J]. Mol Biol Rep， 2022, 49(4):3307-3320. DOI： 10.1007/s11033-021-07069-3.
|
| [6] |
Mousavi A. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy[J]. Immunol Lett， 2020, 217:91-115. DOI： 10.1016/j.imlet.2019.11.007.
|
| [7] |
Altschul SF, Madden TL, Schäffer AA，et al. Gapped BLAST and PSI-BLAST：A new generation of protein database search programs[J]. Nucleic Acids Res， 1997, 25(17):3389-3402. DOI： 10.1093/nar/25.17.3389.
|
| [8] |
Janssens R, Struyf S, Proost P. Pathological roles of the homeostatic chemokine CXCL12[J]. Cytokine Growth Factor Rev， 2018, 44:51-68. DOI： 10.1016/j.cytogfr.2018.10.004.
|
| [9] |
Gros J, Manceau M, Thomé V，et al. A common somitic origin for embryonic muscle progenitors and satellite cells[J]. Nature， 2005, 435(7044):954-958. DOI： 10.1038/nature03572.
|
| [10] |
Kim M, Kim DI, Kim EK，et al. CXCR4 overexpression in human adipose tissue-derived stem cells improves homing and engraftment in an animal limb ischemia model[J]. Cell Transplantation， 2017, 26(2):191-204. DOI： 10.3727/096368916X692708.
|
| [11] |
Cui L, Qu H, Xiao T，et al. Stromal cell-derived factor-1 and its receptor CXCR4 in adult neurogenesis after cerebral ischemia[J]. Restor Neurol Neurosci， 2013, 31(3):239-251. DOI： 10.3233/RNN-120271.
|
| [12] |
Petri RM, Hackel A, Hahnel K，et al. Activated tissue-resident mesenchymal stromal cells regulate natural killer cell immune and tissue-regenerative function[J]. Stem Cell Reports， 2017, 9(3):985-998. DOI： 10.1016/j.stemcr.2017.06.020.
|
| [13] |
Ullah TR. The role of CXCR4 in multiple myeloma：Cells′journey from bone marrow to beyond[J]. J Bone Oncol， 2019, 17:100253. DOI： 10.1016/j.jbo.2019.100253.
|
| [14] |
Li JH, Hamdan FF, Kim SK，et al. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy[J]. Biochemistry， 2008, 47(9):2776-2788. DOI： 10.1021/bi7019113.
|
| [15] |
|
| [16] |
Singh P, Mohammad KS, Pelus LM. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation[J]. Stem Cells， 2020, 38(7):849-859. DOI： 10.1002/stem.3174.
|
| [17] |
García-Cuesta EM, Santiago CA, Vallejo-Díaz J，et al. The role of the CXCL12/CXCR4/ACKR3 axis in autoimmune diseases[J]. Front Endocrinol（Lausanne）， 2019, 10:585. DOI： 10.3389/fendo.2019.00585.
|
| [18] |
Merino JJ, Bellver-Landete V, Oset-Gasque MJ，et al. CXCR4/CXCR7 molecular involvement in neuronal and neural progenitor migration：Focus in CNS repair[J]. J Cell Physiol， 2015, 230(1):27-42. DOI： 10.1002/jcp.24695.
|
| [19] |
Décaillot FM, Kazmi MA, Lin Y，et al. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration[J]. J Biol Chem， 2011, 286(37):32188-32197. DOI： 10.1074/jbc.M111.277038.
|
| [20] |
Yamaguchi J, Kusano KF, Masuo O，et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization[J]. Circulation， 2003, 107(9):1322-1328. DOI： 10.1161/01.cir.0000055313.77510.22.
|
| [21] |
Horton JE, Raisz LG, Simmons HA，et al. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes[J]. Science， 1972, 177(4051):793-795. DOI： 10.1126/science.177.4051.793.
|
| [22] |
Arron JR, Choi Y. Bone versus immune system[J]. Nature， 2000, 408(6812):535-536. DOI： 10.1038/35046196.
|
| [23] |
Takayanagi H, Ogasawara K, Hida S，et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma[J]. Nature， 2000, 408(6812):600-605. DOI： 10.1038/35046102.
|
| [24] |
Okamoto K, Nakashima T, Shinohara M，et al. Osteoimmunology：The conceptual framework unifying the immune and skeletal systems[J]. Physiol Rev， 2017, 97(4):1295-1349. DOI： 10.1152/physrev.00036.2016.
|
| [25] |
Tsukasaki M, Takayanagi H. Osteoimmunology：Evolving concepts in bone-immune interactions in health and disease[J]. Nat Rev Immunol， 2019, 19(10):626-642. DOI： 10.1038/s41577-019-0178-8.
|
| [26] |
Takayanagi H. Osteoimmunology as an intrinsic part of immunology[J]. Int Immunol， 2021, 33(12):673-678. DOI： 10.1093/intimm/dxab057.
|
| [27] |
Greenbaum A, Hsu YMS, Day RB，et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance[J]. Nature， 2013, 495(7440):227-230. DOI： 10.1038/nature11926.
|
| [28] |
Yu VWC, Saez B, Cook C，et al. Specific bone cells produce DLL4 to generate thymus-seeding progenitors from bone marrow[J]. J Exp Med， 2015, 212(5):759-774. DOI： 10.1084/jem.20141843.
|
| [29] |
Mansour A, Abou-Ezzi G, Sitnicka E，et al. Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow[J]. J Exp Med， 2012, 209(3):537-549. DOI： 10.1084/jem.20110994.
|
| [30] |
Teufel S, Grötsch B, Luther J，et al. Inhibition of bone remodeling in young mice by bisphosphonate displaces the plasma cell niche into the spleen[J]. J Immunol， 2014, 193(1):223-233. DOI： 10.4049/jimmunol.1302713.
|
| [31] |
Charles JF, Hsu LY, Niemi EC，et al. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function[J]. J Clin Invest， 2012, 122(12):4592-4605. DOI： 10.1172/JCI60920.
|
| [32] |
Sato M, Asada N, Kawano Y，et al. Osteocytes regulate primary lymphoid organs and fat metabolism[J]. Cell Metab， 2013, 18(5):749-758. DOI： 10.1016/j.cmet.2013.09.014.
|
| [33] |
Dar HY, Azam Z, Anupam R，et al. Osteoimmunology：The Nexus between bone and immune system[J]. Front Biosci （Landmark Ed）， 2018, 23(3):464-492. DOI： 10.2741/4600.
|
| [34] |
Weitzmann MN, Ofotokun I. Physiological and pathophysiological bone turnover-role of the immune system[J]. Nat Rev Endocrinol， 2016, 12(9):518-532. DOI： 10.1038/nrendo.2016.91.
|
| [35] |
Guder C, Gravius S, Burger C，et al. Osteoimmunology：A current update of the interplay between bone and the immune system[J]. Front Immunol， 2020, 11:58. DOI： 10.3389/fimmu.2020.00058.
|
| [36] |
Gravallese EM, Schett G. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis[J]. Nat Rev Rheumatol， 2018, 14(11):631-640. DOI： 10.1038/s41584-018-0091-8.
|
| [37] |
Huang Y, Tian C, Li Q，et al. TET1 knockdown inhibits Porphyromonas gingivalis LPS/IFN-γ-Induced M1 macrophage polarization through the NF-κB pathway in THP-1 cells[J]. Int J Mol Sci， 2019, 20(8):E2023. DOI： 10.3390/ijms20082023.
|
| [38] |
Yu M, D′Amelio P, Tyagi AM，et al. Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice[J]. EMBO Rep， 2018, 19(1):156-171. DOI： 10.15252/embr.201744421.
|
| [39] |
Viniegra A, Goldberg H, Çil Ç，et al. Resolving macrophages counter osteolysis by anabolic actions on bone cells[J]. J Dent Res， 2018, 97(10):1160-1169. DOI： 10.1177/0022034518777973.
|
| [40] |
Ara T, Tokoyoda K, Sugiyama T，et al. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny[J]. Immunity， 2003, 19(2):257-267. DOI： 10.1016/s1074-7613(03)00201-2.
|
| [41] |
Cencioni C, Capogrossi MC, Napolitano M. The SDF-1/CXCR4 axis in stem cell preconditioning[J]. Cardiovasc Res， 2012, 94(3):400-407. DOI： 10.1093/cvr/cvs132.
|
| [42] |
Petit I, Szyper-Kravitz M, Nagler A，et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4[J]. Nat Immunol， 2002, 3(7):687-694. DOI： 10.1038/ni813.
|
| [43] |
Leeper NJ, Hunter AL, Cooke JP. Stem cell therapy for vascular regeneration：Adult，embryonic，and induced pluripotent stem cells[J]. Circulation， 2010, 122(5):517-526. DOI： 10.1161/CIRCULATIONAHA.109.881441.
|
| [44] |
Ko IK, Lee SJ, Atala A，et al. In situ tissue regeneration through host stem cell recruitment[J]. Exp Mol Med， 2013, 45:e57. DOI： 10.1038/emm.2013.118.
|
| [45] |
Ganju RK, Brubaker SA, Meyer J，et al. The alpha-chemokine，stromal cell-derived factor-1alpha，binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways[J]. J Biol Chem， 1998, 273(36):23169-23175. DOI： 10.1074/jbc.273.36.23169.
|
| [46] |
|
| [47] |
Trautmann F, Cojoc M, Kurth I，et al. CXCR4 as biomarker for radioresistant cancer stem cells[J]. Int J Radiat Biol， 2014, 90(8):687-699. DOI： 10.3109/09553002.2014.906766.
|
| [48] |
|
| [49] |
Fadini GP, Ferraro F, Quaini F，et al. Concise review：Diabetes，the bone marrow niche，and impaired vascular regeneration[J]. Stem Cells Transl Med， 2014, 3(8):949-957. DOI： 10.5966/sctm.2014-0052.
|
| [50] |
Wei JN, Cai F, Wang F，et al. Transplantation of CXCR4 overexpressed mesenchymal stem cells augments regeneration in degenerated intervertebral discs[J]. DNA Cell Biol， 2016, 35(5):241-248. DOI： 10.1089/dna.2015.3118.
|
| [51] |
Liekens S, Schols D, Hatse S. CXCL12-CXCR4 axis in angiogenesis，metastasis and stem cell mobilization[J]. Curr Pharm Des， 2010, 16(35):3903-3920. DOI： 10.2174/138161210794455003.
|
| [52] |
Mirshahi F, Pourtau J, Li H，et al. SDF-1 activity on microvascular endothelial cells：Consequences on angiogenesis in in vitro and in vivo models[J]. Thromb Res， 2000, 99(6):587-594. DOI： 10.1016/S0049-3848(00)00292-9.
|
| [53] |
Kijowski J, Baj-Krzyworzeka M, Majka M，et al. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells[J]. Stem Cells， 2001, 19(5):453-466. DOI： 10.1634/stemcells.19-5-453.
|
| [54] |
Molino M, Woolkalis MJ, Prevost N，et al. CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2[J]. Biochim Biophys Acta， 2000, 1500(2):227-240. DOI： 10.1016/s0925-4439(99)00110-6.
|
| [55] |
Döring Y, Pawig L, Weber C，et al. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease[J]. Front Physiol， 2014, 5:212. DOI： 10.3389/fphys.2014.00212.
|
| [56] |
Jin F, Brockmeier U, Otterbach F，et al. New insight into the SDF-1/CXCR4 axis in a breast carcinoma model：Hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation[J]. Mol Cancer Res， 2012, 10(8):1021-1031. DOI： 10.1158/1541-7786.MCR-11-0498.
|
| [57] |
Wagner NM, Bierhansl L, Nöldge-Schomburg G，et al. Toll-like receptor 2-blocking antibodies promote angiogenesis and induce ERK1/2 and AKT signaling via CXCR4 in endothelial cells[J]. Arterioscler Thromb Vasc Biol， 2013, 33(8):1943-1951. DOI： 10.1161/ATVBAHA.113.301783.
|
| [58] |
Salvucci O, Basik M, Yao L，et al. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma[J]. J Leukoc Biol， 2004, 76(1):217-226. DOI： 10.1189/jlb.1203609.
|
| [59] |
Moser B, Loetscher P. Lymphocyte traffic control by chemokines[J]. Nat Immunol， 2001, 2(2):123-128. DOI： 10.1038/84219.
|
| [60] |
Pozzobon T, Goldoni G, Viola A，et al. CXCR4 signaling in health and disease[J]. Immunol Lett， 2016, 177:6-15. DOI： 10.1016/j.imlet.2016.06.006.
|
| [61] |
Payne D, Drinkwater S, Baretto R，et al. Expression of chemokine receptors CXCR4，CXCR5 and CCR7 on B and T lymphocytes from patients with primary antibody deficiency[J]. Clin Exp Immunol， 2009, 156(2):254-262. DOI： 10.1111/j.1365-2249.2009.03889.x.
|
| [62] |
Nauseef WM, Borregaard N. Neutrophils at work[J]. Nat Immunol， 2014, 15(7):602-611. DOI： 10.1038/ni.2921.
|
| [63] |
Uhl B, Vadlau Y, Zuchtriegel G，et al. Aged neutrophils contribute to the first line of defense in the acute inflammatory response[J]. Blood， 2016, 128(19):2327-2337. DOI： 10.1182/blood-2016-05-718999.
|
| [64] |
Hampton HR, Bailey J, Tomura M，et al. Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes[J]. Nat Commun， 2015, 6:7139. DOI： 10.1038/ncomms8139.
|
| [65] |
Martin C, Burdon PCE, Bridger G，et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence[J]. Immunity， 2003, 19(4):583-593. DOI： 10.1016/s1074-7613(03)00263-2.
|
| [66] |
Leung TH, Snyder ER, Liu Y，et al. A cellular，molecular，and pharmacological basis for appendage regeneration in mice[J]. Genes Dev， 2015, 29(20):2097-2107. DOI： 10.1101/gad.267724.115.
|
| [67] |
Chen H, Li G, Liu Y，et al. Pleiotropic roles of CXCR4 in wound repair and regeneration[J]. Front Immunol， 2021, 12:668758. DOI： 10.3389/fimmu.2021.668758.
|
| [68] |
Gómez-Barrena E, Rosset P, Gebhard F，et al. Feasibility and safety of treating non-unions in tibia，femur and humerus with autologous，expanded，bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric，non-comparative trial[J]. Biomaterials， 2019, 196:100-108. DOI： 10.1016/j.biomaterials.2018.03.033.
|
| [69] |
García-García A, de Castillejo CLF, Méndez-Ferrer S. BMSCs and hematopoiesis[J]. Immunol Lett， 2015, 168(2):129-135. DOI： 10.1016/j.imlet.2015.06.020.
|
| [70] |
Hutchings G, Moncrieff L, Dompe C，et al. Bone regeneration，reconstruction and use of osteogenic cells；from basic knowledge，animal models to clinical trials[J]. J Clin Med， 2020, 9(1):E139. DOI： 10.3390/jcm9010139.
|
| [71] |
Chen L, Li Y, Chen W，et al. Enhanced recruitment and hematopoietic reconstitution of bone marrow-derived mesenchymal stem cells in bone marrow failure by the SDF-1/CXCR4[J]. J Tissue Eng Regen Med， 2020, 14(9):1250-1260. DOI： 10.1002/term.3096.
|
| [72] |
Zhao A, Chung M, Yang Y，et al. The SDF-1/CXCR4 signaling pathway directs the migration of systemically transplanted bone marrow mesenchymal stem cells towards the lesion site in a rat model of spinal cord injury[J]. Curr Stem Cell Res Ther， 2023, 18(2):216-230. DOI： 10.2174/1574888X17666220510163245.
|
| [73] |
Liu N, Patzak A, Zhang J. CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury[J]. Am J Physiol Renal Physiol， 2013, 305(7):F1064-F1073. DOI： 10.1152/ajprenal.00178.2013.
|
| [74] |
Guang LG, Boskey AL, Zhu W. Regulatory role of stromal cell-derived factor-1 in bone morphogenetic protein-2-induced chondrogenic differentiation in vitro[J]. Int J Biochem Cell Biol， 2012, 44(11):1825-1833. DOI： 10.1016/j.biocel.2012.06.033.
|
| [75] |
Potter ML, Smith K, Vyavahare S，et al. Characterization of differentially expressed miRNAs by CXCL12/SDF-1 in human bone marrow stromal cells[J]. Biomol Concepts， 2021, 12(1):132-143. DOI： 10.1515/bmc-2021-0015.
|
| [76] |
Zhu W, Boachie-Adjei O, Rawlins BA，et al. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells[J]. J Biol Chem， 2007, 282(26):18676-18685. DOI： 10.1074/jbc.M610232200.
|
| [77] |
Kollet O, Dar A, Shivtiel S，et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells[J]. Nat Med， 2006, 12(6):657-664. DOI： 10.1038/nm1417.
|
| [78] |
Zhang C, Zhang W, Zhu D，et al. Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy[J]. J Nanobiotechnology， 2022, 20(1):35. DOI： 10.1186/s12951-021-01231-6.
|
| [79] |
Cross M, Smith E, Hoy D，et al. The global burden of hip and knee osteoarthritis：Estimates from the global burden of disease 2010 study[J]. Ann Rheum Dis， 2014, 73(7):1323-1330. DOI： 10.1136/annrheumdis-2013-204763.
|
| [80] |
Mathiessen A, Conaghan PG. Synovitis in osteoarthritis：Current understanding with therapeutic implications[J]. Arthritis Res Ther， 2017, 19(1):18. DOI： 10.1186/s13075-017-1229-9.
|
| [81] |
Bagi CM, Berryman ER, Teo S，et al. Oral administration of undenatured native chicken typeⅡ collagen （UC-Ⅱ） diminished deterioration of articular cartilage in a rat model of osteoarthritis （OA）[J]. Osteoarthritis Cartilage， 2017, 25(12):2080-2090. DOI： 10.1016/j.joca.2017.08.013.
|
| [82] |
Wang G, Li Y, Meng X，et al. The study of targeted blocking SDF-1/CXCR4 signaling pathway with three antagonists on MMPs，typeⅡ collagen，and aggrecan levels in articular cartilage of guinea pigs[J]. J Orthop Surg Res， 2020, 15(1):195. DOI： 10.1186/s13018-020-01646-1.
|
| [83] |
Li J, Chen H, Zhang D，et al. The role of stromal cell-derived factor 1 on cartilage development and disease[J]. Osteoarthritis Cartilage， 2021, 29(3):313-322. DOI： 10.1016/j.joca.2020.10.010.
|
| [84] |
Lu W, He Z, Shi J，et al. AMD3100 attenuates post-traumatic osteoarthritis by maintaining transforming growth factor-β1-induced expression of tissue inhibitor of metalloproteinase-3 via the phosphatidylinositol 3-kinase/akt pathway[J]. Front Pharmacol， 2019, 10:1554. DOI： 10.3389/fphar.2019.01554.
|
| [85] |
Lu W, Shi J, Zhang J，et al. CXCL12/CXCR4 axis regulates aggrecanase activation and cartilage degradation in a post-traumatic osteoarthritis rat model[J]. Int J Mol Sci， 2016, 17(10):E1522. DOI： 10.3390/ijms17101522.
|
| [86] |
Qin H, Zhao X, Hu YJ，et al. Inhibition of SDF-1/CXCR4 axis to alleviate abnormal bone formation and angiogenesis could improve the subchondral bone microenvironment in osteoarthritis[J]. Biomed Res Int， 2021:8852574. DOI： 10.1155/2021/8852574.
|
| [87] |
Zhang Y, Li X, Li J，et al. Knee loading enhances the migration of adipose-derived stem cells to the osteoarthritic sites through the SDF-1/CXCR4 regulatory axis[J]. Calcif Tissue Int， 2022, 111(2):171-184. DOI： 10.1007/s00223-022-00976-y.
|
| [88] |
Zhang X, Sun Y, Chen W，et al. Nanoparticle functionalization with genetically-engineered mesenchymal stem cell membrane for targeted drug delivery and enhanced cartilage protection[J]. Biomater Adv， 2022, 136:212802. DOI： 10.1016/j.bioadv.2022.212802.
|
| [89] |
Zhou S, Lu H, Xiong M. Identifying immune cell infiltration and effective diagnostic biomarkers in rheumatoid arthritis by bioinformatics analysis[J]. Front Immunol， 2021, 12:726747. DOI： 10.3389/fimmu.2021.726747.
|
| [90] |
Bragg R, Gilbert W, Elmansi A M，et al. Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis[J]. Ther Adv Chronic Dis， 2019, 10:20406 22319882531. DOI： 10.1177/2040622319882531.
|
| [91] |
Kim KW, Cho ML, Kim HR，et al. Up-regulation of stromal cell-derived factor 1 （CXCL12） production in rheumatoid synovial fibroblasts through interactions with T lymphocytes：Role of interleukin-17 and CD40L-CD40 interaction[J]. Arthritis and Rheumatism， 2007, 56(4):1076-1086. DOI： 10.1002/art.22439.
|
| [92] |
Chen HT, Tsou HK, Hsu CJ，et al. Stromal cell-derived factor-1/CXCR4 promotes IL-6 production in human synovial fibroblasts[J]. J Cell Biochem， 2011, 112(4):1219-1227. DOI： 10.1002/jcb.23043.
|
| [93] |
Peng L, Zhu N, Mao J，et al. Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity[J]. Exp Ther Med， 2020, 20(3):1925-1934. DOI： 10.3892/etm.2020.8950.
|
| [94] |
Wang S, Zhou C, Zheng H，et al. Chondrogenic progenitor cells promote vascular endothelial growth factor expression through stromal-derived factor-1[J]. Osteoarthritis Cartilage， 2017, 25(5):742-749. DOI： 10.1016/j.joca.2016.10.017.
|
| [95] |
Samarpita S, Rasool M. Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis[J]. Cytokine， 2021, 142:155502. DOI： 10.1016/j.cyto.2021.155502.
|
| [96] |
Cecchinato V, D′Agostino G, Raeli L，et al. Redox-mediated mechanisms fuel monocyte responses to CXCL12/HMGB1 in active rheumatoid arthritis[J]. Front Immunol， 2018, 9:2118. DOI： 10.3389/fimmu.2018.02118.
|
| [97] |
He Y, Chen Y. The potential mechanism of the microbiota-gut-bone axis in osteoporosis：A review[J]. Osteoporos Int， 2022, 33(12):2495-2506. DOI： 10.1007/s00198-022-06557-x.
|
| [98] |
Sözen T, Özişik L, Başaran NÇ. An overview and management of osteoporosis[J]. Eur J Rheumatol， 2017, 4(1):46-56. DOI： 10.5152/eurjrheum.2016.048.
|
| [99] |
Liu Q, Zhang X, Jiao Y，et al. In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats[J]. Int J Mol Med， 2018, 41(2):669-678. DOI： 10.3892/ijmm.2017.3280.
|
| [100] |
Garg P, Mazur MM, Buck AC，et al. Prospective review of mesenchymal stem cells differentiation into osteoblasts[J]. Orthop Surg， 2017, 9(1):13-19. DOI： 10.1111/os.12304.
|
| [101] |
Guang LG, Boskey AL, Zhu W. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells[J]. Int J Biochem Cell Biol， 2013, 45(8):1813-1820. DOI： 10.1016/j.biocel.2013.05.034.
|
| [102] |
Gilbert W, Bragg R, Elmansi AM，et al. Stromal cell-derived factor-1 （CXCL12） and its role in bone and muscle biology[J]. Cytokine， 2019, 123:154783. DOI： 10.1016/j.cyto.2019.154783.
|
| [103] |
Bai J, Ge G, Wang Q，et al. Engineering stem cell recruitment and osteoinduction via bioadhesive molecular mimics to improve osteoporotic bone-implant integration[J]. Research （Wash D C）， 2022:9823784. DOI： 10.34133/2022/9823784.
|
| [104] |
Hu Y, Li X, Zhang Q，et al. Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss[J]. Bioact Mater， 2021, 6(9):2905-2913. DOI： 10.1016/j.bioactmat.2021.02.014.
|
| [105] |
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis：Framework and proposal of a new classification and case definition[J]. J Periodontol， 2018, 89(Suppl 1):S159-S172. DOI： 10.1002/JPER.18-0006.
|
| [106] |
Sun X, Gao J, Meng X，et al. Polarized macrophages in periodontitis：Characteristics，function，and molecular signaling[J]. Front Immunol， 2021, 12:763334. DOI： 10.3389/fimmu.2021.763334.
|
| [107] |
Bosshardt DD. The periodontal pocket：Pathogenesis，histopathology and consequences[J]. Periodontology 2000, 2018,76(1):43-50. DOI： 10.1111/prd.12153.
|
| [108] |
Zhang X, Jin Y, Wang Q，et al. Autophagy-mediated regulation patterns contribute to the alterations of the immune microenvironment in periodontitis[J]. Aging （Albany NY）， 2020, 13(1):555-577. DOI： 10.18632/aging.202165.
|
| [109] |
Zhang Z, Zheng Y, Bian X，et al. Identification of key genes and pathways associated with oxidative stress in periodontitis[J]. Oxid Med Cell Longev， 2022:9728172. DOI： 10.1155/2022/9728172.
|
| [110] |
Arjunan P, Meghil MM, Pi W，et al. Oral pathobiont activates anti-apoptotic pathway，promoting both immune suppression and oncogenic cell proliferation[J]. Sci Rep， 2018, 8(1):16607. DOI： 10.1038/s41598-018-35126-8.
|
| [111] |
Yamashiro K, Ideguchi H, Aoyagi H，et al. High mobility Group Box 1 expression in oral inflammation and regeneration[J]. Front Immunol， 2020, 11:1461. DOI： 10.3389/fimmu.2020.01461.
|
| [112] |
Luo H, Chen D, Li R，et al. Genetically engineered CXCR4-modified exosomes for delivery of miR-126 mimics to macrophages alleviate periodontitis[J]. J Nanobiotechnology. 2023, 21(1):116. DOI： 10.1186/s12951-023-01863-w.
|
| [113] |
Mehta SA, Christopherson KW, Bhat-Nakshatri P，et al. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells：Implications of p53 mutation or isoform expression on breast cancer cell invasion[J]. Oncogene， 2007, 26(23):3329-3337. DOI： 10.1038/sj.onc.1210120.
|
| [114] |
Orimo A, Gupta PB, Sgroi DC，et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion[J]. Cell， 2005, 121(3):335-348. DOI： 10.1016/j.cell.2005.02.034.
|
| [115] |
Chinni SR, Yamamoto H, Dong Z，et al. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone[J]. Mol Cancer Res， 2008, 6(3):446-457. DOI： 10.1158/1541-7786.MCR-07-0117.
|
| [116] |
Lai TH, Fong YC, Fu WM，et al. Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells[J]. J Cell Physiol， 2009, 218(2):334-342. DOI： 10.1002/jcp.21601.
|
| [117] |
Lu Y, Hu B, Guan GF，et al. SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway[J]. Med Oncol， 2015, 32(7):194. DOI： 10.1007/s12032-015-0576-0.
|
| [118] |
Xi Y, Qi Z, Ma J，et al. PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells[J]. Clin Exp Metastasis， 2020, 37(1):173-185. DOI： 10.1007/s10585-019-09998-7.
|
| [119] |
Liu J, Feng G, Li Z，et al. Long non-coding RNA FEZF1-AS1 modulates CXCR4 to promote cell proliferation，warburg effect and suppress cell apoptosis in osteosarcoma by sponging miR-144[J]. Onco Targets Ther， 2020, 13:2899-2910. DOI： 10.2147/OTT.S235970.
|